Combination Products Executive Forum to be Hosted by CHI's Pharmaceutical Strategy Series Business Executives, Pricing Analysts, and IP Professionals Meet on Expanding their Combination Products Research and Partnerships on June 1-2, 2009 in Cambridge, MA. (PRWeb Feb 13, 2009)
Read the full story at http://www.prweb.com/releases/2009/02/prweb2051004.htm
Source: www.prweb.comEvolutionary Link To Modern-Day Obesity, Other Problems That irresistible craving for a cheeseburger has its roots in the dramatic growth of the human brain and body that resulted from environmental changes some 2 million years ago. Higher quality, nutritionally dense diets became necessary to fuel the high-energy demands of humans' exceptionally large brains and for developing the first rudimentary hunting and gathering economy.
Source: www.medicalnewstoday.comVermillion Presents Critical Data From Its OVA1 Clinical Trial Vermillion, Inc. (OTC Bulletin Board: VRML), a molecular diagnostics company, presented data from its prospective OVA1 clinical trial at the Society of Gynecologic Oncologists' (SGO) 40th Annual Meeting on Women's Cancer in San Antonio, TX (Poster 196).
Source: www.medicalnewstoday.comFewer Vagal Nerve Stimulation Operations In Scotland Than England And Wales Compared with the rest of the UK, fewer people in Scotland are fitted with vagal nerve stimulation (VNS) devices to treat their epilepsy. To discover the reasons, Epilepsy Scotland has invited two clinicians, Dundee-based Richard Roberts and Richard Selway from London, to explore VNS from both sides of the border. This free debate for health professionals is Friday 13 February in Glasgow's Teachers Building from 6.30-8.30pm.
Source: www.medicalnewstoday.com
# posted by Network @ 11:45 AM